By Ben Leonard and Lauren Gardner

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.